Effect of anti-inflammatory supplementation with whey peptide and exercise therapy in patients with COPD

Respiratory Medicine

Volumn 106, Issue 11, 2012, Pages 1526-1534

  Sugawara, Keiyu ^a   Takahashi, Hitomi ^a   Kashiwagura, Takeshi ^a   Yamada, Kohko ^a   Yanagida, Satoko ^a   Homma, Mitsunobu ^a   Dairiki, Kazuo ^b   Sasaki, Hajime ^b   Kawagoshi, Atsuyoshi ^c   Satake, Masahiro ^c   Shioya, Takanobu ^c  

^a Akita City General Hospital   (Japan)

^b MEIJI DAIRIES CORPORATION   (Japan)

^c AKITA UNIVERSITY   (Japan)

Author keywords

Anti inflammatory nutritional supplementation therapy; Chronic obstructive pulmonary disease (COPD); Pulmonary rehabilitation; Whey peptide

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ASCORBIC ACID; BETA CAROTENE; BIOTIN; C REACTIVE PROTEIN; CALCIUM; COPPER; CYTOKINE; INTERLEUKIN 8; LIPID; MEIN; MILK PROTEIN; PROTEIN; RETINOL; SACCHARIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC;

AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CALORIC INTAKE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; EMOTION; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; KINESIOTHERAPY; MALE; MUSCLE STRENGTH; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; SKELETAL MUSCLE; WHEY;

AGED; ANTI-INFLAMMATORY AGENTS; COMBINED MODALITY THERAPY; DIETARY SUPPLEMENTS; ENERGY INTAKE; EXERCISE THERAPY; FEMALE; HUMANS; MALE; MILK PROTEINS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 84866306100     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.07.001     Document Type: Article

References (45)

1. A.M.W.J. Schols, W.A. Buurman, and A.J.S. del Brekel Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in subgroup of patients with chronic obstructive pulmonary disease Thorax 51 1996 819 824 (Pubitemid 26274084)
2. R. Broekhuizen, E.F.M. Wouters, E.C. Creutzberg, and A.M.W.J. Schols Raised CRP levels mark metabolic and functional impairment in advanced COPD Thorax 61 2006 17 22 (Pubitemid 43106972)
3. A.G.N. Agusti, J. Sauleda, and C. Miralles Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 2002 485 489
4. Global initiative for chronic obstructive lung disease, global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2006 National Heart, Lung and Blood Institute Bethesda NHLBI/WHO Workshop Report. GOLD website www.goldcopd.com April, 2001 (Update 2006)
5. W.R. Perera, J.R. Hurst, and T.M.A. Wilkinson Inflammatory changes, recovery and recurrence at COPD exacerbation Eur Respir J 29 2007 527 534 (Pubitemid 46372101)
6. I.M. Ferreira, D. Brooks, and Y. Lacasse Nutritional supplementation for stable chronic obstructive pulmonary disease Cochrane Database Syst Rev 18 2005 Review
7. L. Laviolette, L.C. Lands, and N. Daulebaev Combined effect of dietary supplementation with pressurized whey and exercise training in chronic obstructive pulmonary disease: a randomized, controlled, double blind study J Med Food 13 3 2010 589 598
8. K. Sugawara, H. Takahashi, and C. Kasai Effects of nutritional supplementation combined with low-intensity exercise in malnourished patients with COPD Respir Med 104 2 2010 1183 1889
9. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 152 1995 S77 S120
10. World Medical Association Declaration of Helsinki Ethical principles for medical research involving human subjects Bull World Health Organ 79 2001 373 374
11. T. Tamura, N. Ichinoseki, T. Yoshimura, and Y. Torii Development and evaluation of a simple calorimeter for the measurement of resting metabolism Clin Exp Pharmacol Physiol 29 2002 S2 S6 (Pubitemid 35278961)
12. J.B. Weir New methods for calculating metabolic rate with special reference to protein metabolism J Physiol 109 1949 1 9
13. N. Hosoya Reference values of anthropometric data in Japanese (JARD2001) Eiyou Hyouka 19 2002 52 63 [in Japanese]
14. L.F. Black, and R.E. Hyatt Maximal respiratory pressures: normal values and relationship to age and sex Am Rev Respir Dis 138 1969 696 702
15. American Thoracic Society ATS statement: guideline for the six-minute walk test Am J Respir Crit Care Med 166 2002 111 117
16. H. Kagaya, H. Takahashi, and K. Sugawara Effective home-based pulmonary rehabilitation in patients with restrictive lung diseases Tohoku J Exp Med 218 2009 215 219
17. G.H. Guyatt, L.B. Berman, and M. Townsend A measure of quality of life for clinical trials in chronic lung disease Thorax 42 1987 773 778 (Pubitemid 17142007)
18. R. Jaeschke, J. Singer, and G.H. Guyatt Measurement of health status: ascertaining the minimal clinically important difference Control Clin Trials 10 1989 407 415 (Pubitemid 20025670)
19. H. Sasaki, and H. Kume Nutritional and physiological effects of peptides from whey Bull Int Dairy Fed 417 2007 43 50
20. M. Yamaguchi, and K. Uchida MHN-02, liquid food combined with whey peptides, suppresses interleukin-6 release after intestinal ischemia/reperfusion in rats Milk Science 57 3 2008 87 90
21. T. Takayanagi, H. Sasaki, and A. Kawashima A new enteral diet, MHN-02, which contains abundant antioxidants and whey peotide, protects against carbon tetrachloride-induced hepatitis J Parenter Enteral Nutr 35 4 2011 516 522
22. I. Homma Respiratory muscle stretching and exercise N.S. Cherniack, M.D. Altose, I. Homma, Rehabilitation of the patients with respiratory disease 1999 McGraw-Hill New York, NY 455 461
23. G. Strassman, M. Fong, and J.S. Kenney Evidence for the involvement of interleukin 6 in experimental cancer cachexia J Clin Invest 89 5 1992 1681 1684
24. D.P. Kotler Cachexia. Ann Intern Med 133 2000 622 634
25. M. Di Francia, D. Barbier, and J.L. Mege Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease Am J Respir Crit Care Med 150 1994 1453 1455 (Pubitemid 24356667)
26. I. De Godoy, M. Donahoe, and W.J. Calhoun Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients Am J Respir Crit Care Med 153 1996 633 637
27. M. Visser, M. Pahor, and D.R. Taaffe Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the health ABC study J Gerontol Med Sci 57 2002 326 332
28. R.A. Stockly Neutrophils and the pathogenesis of COPD Chest 121 Suppl. 2002 151S 155S
29. P.J. Barnes Mediators of chronic obstructive pulmonary disease Pharmacol Rev 56 2004 515 548 (Pubitemid 39658462)
30. W. Matsuyama, H. Mitsuyama, and M. Watanabe Effects of omega-3 polyunsaturated fatty acids on inflammatory markers in COPD Chest 128 2005 3817 3827 (Pubitemid 43062641)
31. R. Broekhuizen, E.F. Wouters, and E.C. Creuzberg Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease Thorax 50 5 2005 376 382 (Pubitemid 40685819)
32. M. Yamaguchi, and M. Uchida α-Lactalbumin suppresses interleukin-6 release after intestinal ischemia/reperfusion via nitric oxide in rats Immunopharmacology 15 2007 43 47 (Pubitemid 46333880)
33. M. Yamaguchi, K. Yoshida, and M. Uchida Novel functions of bovine milk-derived α-lactalbumin: anti-nociceptive and anti-inflammatory activity caused by inhibiting cyclooxygenase-2 and phospholopase A2 Biol Pharm Bull 32 3 2009 366 371
34. I. Mattsby-Baltzer, A. Roseanu, and C. Motas Lactoferrin or a fragment of thereof inhibits theendoxin-induced interleukin-6 response in human monocytic cells Pediatr Res 40 1996 257 262 (Pubitemid 26249678)
35. M. Yamaguchi, M. Matsuura, and K. Kobayashi Lactoferrin protects against development of hepatitis caused by sensitization on Kupffer cells by lipopolysaccharide Clin Diagn Lab Immunol 8 6 2001 1234 1239 (Pubitemid 33035761)
36. H. Kume, K. Okazaki, and H. Sasaki Hepatoprotective effects of whey protein on d-galactosamine-induced hepatitis and liver fibrosis in rats Biosci Biotechnol Biochem 70 2006 1281 1285 (Pubitemid 43765267)
37. B.K. Pedersen, and M.A. Febbraio Muscle as an endocrine organ: focus on muscle-derived interleukin-6 Physiol Rev 88 2006 1379 1406
38. A.M.W. Petersen, and B.K. Pedersen The anti-inflammatory effect of exercise J Appl Physiol 98 2005 1154 1162 (Pubitemid 40396484)
39. C.P. Fisher, P. Plomgaard, and A.K. Hansen Endurance training reduces the contraction-induced interleukin-6 mRNA expression in human skeletal muscle Am J Physiol Endcrinol Metab 287 2004 E1189 E1194 (Pubitemid 39491961)
40. E.F. Rosa, A.C. Silva, and S.S. Ihara Habitual exercise program protects murine intestinal skeletal and cardiac muscles against aging J Appl Physiol 99 4 2005 1569 1575 (Pubitemid 43014368)
41. J.S. Greiwe, B. Cheng, and D.C. Rubin Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans FASEB J 15 2001 475 482 (Pubitemid 32141439)
42. M.C. Steiner, R.L. Barton, S.J. Singh, and M.D.L. Morgan Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomized control trial Thorax 58 2003 745 751 (Pubitemid 37094048)
43. J.W. Helge, E.A. Richter, and B. Kiens Interaction of training and diet on metabolism and endurance during exercise in man J Appl Physiol 61 1986 165 172
44. S.M. Phillips, J.W. Hartman, and S.B. Wilkinson Dietary protein to support anabolism with resistance exercise in young men J Am Coll Nutr 24 2005 134 139
45. E.C. Creutzberg, E.F. Wouters, and A.M. Schols Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease Nutrition 19 2003 120 127 (Pubitemid 36196765)